Top Markets
Coin of the day
MDxHealth S.A. MDxHealth S.A.

MDxHealth S.A.

MDXH
Rang in aandelen #21732
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Aandeelprijs
$3.58
Laatst gesynchroniseerd: 2023-12-15
Marktkapitalisatie
$101.57M
Verandering (1 dag)
3.79%
Verandering (1 jaar)
0.00%
Land
BE
Handel MDxHealth S.A. (MDXH)

Categorie

Dividendrendementgeschiedenis voor MDxHealth S.A. (MDXH)
Het dividendrendement (TTM) van MDxHealth S.A. (aandelsymbool: MDXH) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van MDxHealth S.A. (MDXH) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten